Back to AKTS
Merck & Co., Inc. AKTS Position History
Aktis Oncology, Inc. • Healthcare
Quarters held
3
Latest value
$18.6M
Q3 2026
Peak value
$30.7M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $17M |
| Q2 2026 | $30.7M |
| Q3 2026 | $18.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $18.6M | 952.8K | — | — |
| Q2 2026 | $30.7M | 952.8K | — | — |
| Q1 2026 | $17M | 952.8K | — | — |
Other funds holding AKTS
$155.9M
$155.5M
$94.2M
$93.9M
$86.5M
$86.3M